Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging

Current Topics in Medicinal Chemistry

Volumn 13, Issue 4, 2013, Pages 479-487

  Sasser, Todd A ^a,b   van Avermaete, Ashley E ^a   White, Alexander ^a   Chapman, Sarah ^a   Johnson, James R ^c   van Avermaete, Tony ^a   Gammon, Seth T ^b   Leevy, W Matthew ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b Carestream Molecular Imaging   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial infection; In vivo molecular imaging; Nuclear medicine; Probe development

Indexed keywords

AADIOLABELED CYTOKINE; AVIDIN; BACTERISENSE 645; CIPROFLOXACIN; CYANIDE; DIPICOLYLAMINE ZINC; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; MALTODEXTRIN; PROTHROMBIN; PSVUE 643; PSVUE 794; RADIOLABELED ANTIBIOTIC AGENT; RADIOLABELED ANTIBODY; RADIOLABELED PEPTIDE; RADIOPHARMACEUTICAL AGENT; SIDEROPHORE; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FLUORESCENCE MICROSCOPY; HUMAN; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BACTERIA; BACTERIAL INFECTIONS; FLUORESCENT DYES; HUMANS; MOLECULAR IMAGING; NUCLEAR MEDICINE;

EID: 84878771576     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611313040008     Document Type: Review

References (48)

1. Goldsmith, SJ.; Vallabhajosula, S. Clinically proven radiopharmaceuticalsfor infection imaging: mechanisms and applications.Semin. Nucl. Med. 2009, 39, 2-10.
2. Signore, A.; Glaudemans, A.W. The molecular imaging approachto image infections and inflammation by nuclear medicine techniques.The Japanese Society of Nuclear Medicine. 2011, 25, 681-700.
3. 67Ga-Citrate. J. Nuc. Med. Tech. 2003, 31(4), 196-201.
4. Akhtar, M.S.; Imran, M.B.; Nadeem, M.A.; Shahid, A. Antimicrobialpeptides as infection imaging agents: better than radiolabeledantibiotics. Int. J. Pept. 2012, 965238.
5. Leevy, W.M.; Serazin, N.; Smith, B.B. Optical imaging of bacterialinfection models. Drug Discov. Today Dis. Models. 2007, 4, 91-97.
6. Leevy, W.M.; Johnson, J.R.; Lakshmi, C.; Morris, J.; Marquez, M.; Smith, B.D. Selective recognition of bacterial membranes byzinc(II)-coordination complexes. Chem. Commun. 2006, 15, 1595-1597.
7. Leevy, W.M.; Gammon, S.T.; Jiang, H.; Johnson, J.R.; Maxwell, D.J.; Jackson, E.N.; Marquez, M.; Piwnica-Worms, D. Optical imagingof bacterial infection in living mice using a fluorescent nearinfraredmolecular probe. J. Am. Chem. Soc. 2006, 128, 16476-16477.
8. White, A. G.; Gray, B.D.; Pak, K.Y.; Smith, B.D. Deep-red fluorescentimaging probe for bacteria. Bioorg. Med. Chem. Lett. 2012,22, 2833-2836.
9. Liu, X.; Cheng, D.; Gray, B.D.; Wang, Y.; Akalin, A.; Rusckowaski, M.; Park, K.Y.; Hnatowich, D.J. Radiolabeled Zn-DPA asa potential infection imaging agent. Nucl. Med. Biol. 2012, 39, 709-714.
10. Thakur, M.L.; Zhang, K.; Paudyal, B.; Devakumar, D.; Covarrubias, M.Y.; Chen, C.; Gray, B.D.; Wickstrom, E.; Park, K.Y. Targetingapoptosis for optical imaging of infection. Mol. ImagingBiol. 2012, 14, 163-171.
11. White, A.G.; Fu, N.; Leevy, W.M.; Lee, J.J.; Blasco, M.A.; Smith, B.D. Optical imaging of bacteria infection in living mice usingdeep-red fluorescent squaraine rotaxane probes. Bioconjug. Chem.2010, 21, 1297-1304.
12. Leevy, W.M.; Lambert, T.N.; Johnson, J.R.; Morris, J.; Smith, B.D. Quantum dot probes for bacteria distinguish Escherichia coli mutantsand permit in vivo imaging. Chem. Commun. 2008, 20, 2331-2333.
13. Leevy, W.M.; Gammon, S.; Johnson, J.; Lampkins, A.; Jiang, H.; Marquez, M.; Piwnica-Worms, D.; Suckow, M.; Smith, B. Noninvasiveoptical imaging of Staphylococcus aureus bacterial infectionin living mice using a Bis-dipicolylamine-Zinc(II) affinity groupconjugated to a near-infrared fluorophore. Bioconjug. Chem. 2008,19, 686-692.
14. Panizzi, P.; Nahrendorf, M.; Figueiredo, J.; Panizzi, J.; Marinelli, B.; Iwamoto, Y.; Keliher, E.; Maddur, AA.; Waterman, P.; Kroh, H.; Leuschner, F.; Aikawa, E.; Swirski, FK.; Pittet, MJ.; Hackeng, TM.; Fuentes-Prior, P.; Schneewind, O.; Bock, PE.; Weissleder, R. In vivo detection of Staphylococcus aureus endocarditis by targetingpathogen-specific prothrombin activation. Nat. Med. 2011, 17,1142-1146.
15. 18F-FDG PET and PET/CT in fever of unknown origin. J. Nucl. Med. 2007, 48, 35-45.
16. Petruzzi, N.; Shanthly, N.; Thakur, M. Recent trends in soft tissueinfection imaging. Semin. Nucl. Med. 2009, 39, 115-123.
17. Palestro, C.J.; Love, C.; Marwin, S.E. Nuclear medicine of thepainful joint replacement. Appl. Radiol. 2006, 35, 22-32.
18. Palestro, C.J.; Love, C.; Bhargava, K.K. Labeled leukocyte imaging:current status and future directions. Q. J. Nucl. Med. Mol. Imaging.2009, 53, 105-123.
19. Kumar, V. Radiolabled white blood cells and direct targeting ofmicro-organisms for infection imaging. Q. J. Nucl. Med. Mol. Imaging.2005, 49, 325-338.
20. Rini, J.N; Palestro, C. J. Imaging of infection and inflammationwith F-FDG-labeled leukocytes. Q. J. Nucl. Med. Mol. Imaging.2006, 50, 143-146.
21. Palestro, C.J.; Love C.; Tronco G.G.; Tomas, M.B.; Rini J.N. Combined labeled leukocyte and technetium 99m sulfur colloidbone marrow imaging for diagnosing musculoskeletal infection.Radiographics. 2006, 26, 859-870.
22. Klingensmith III W. C.; Perlman, D.; Baum, K. Intrapatient comparisonof 2-Deoxy-2-F-18]fluoro-D-glucose with positron emissioncomputed tomography/computed tomography to Tc-99mFanolesomab (Neutrospec) for localization of infection. Mol. Img.& Biol. 2007, 9, 295-299.
23. Chianelli, M.; Boerman, O.C.; Malviya, G.; Galli, F.; Oyen, W.J.G.; Signore, A. Receptor binding ligands to image infection.Cur. Pharm. Des. 2008, 14, 3316-3325.
24. 99mTc-PEG liposomes for scintigraphic detection of infectionand inflammation: clinical evaluation. J. Nucl. Med. 2000, 41, 622-630.
25. Basu, S.; Chryssikos, B.A.; Moghadam-Kia, S.: Zhuang, H.; Torigian, D.A.; Alavi, A. Positron emission tomography as a diagnostictool in infection: present role and future possibilities. Semin. Nucl.Med. 2009, 39, 36-51.
26. Lucignani, G. The many roads to infection imaging. Eur. J. Nucl.Med. Mol. Imaging. 2007, 34, 1873-1877.
27. De Winter, F.; Vogelaers, D.; Gemmel, F.; Dierckx, R.A. Promisingrole of 18-F-fluoro-D-deoxyglucose positron emission tomographyin clinical infectious diseases. Eur. J. Clin. Microbiol.Infect. Dis. 2002, 21, 247-257.
28. Ferro-Flores, G.; Ocampo-Garcia, B.; Melendez-Alafort, L. Developmentof specific radiopharmaceuticals for infection imaging bytargeting infectious micro-organisms. Curr. Pharm. Des. 2012, 18,1098-1106.
29. Lambrecht, F.Y. Evaluation of Tc-labeled antibiotics for infectiondetection. Ann. Nucl. Med. 2011, 25, 1-6.
30. Oyen, W.J.G.; Corstens, F.H.M.; Boerman O.C. Discriminatinginfection from sterile inflammation: can radiolabelled antibioticssolve the problem? Eur. J. Nucl. Mol. Imaging. 2005, 32, 151-152.
31. 99mTc-Antimicrobial peptides: promising candidates for infectionimaging. Q. J. Nucl. Med. 2003, 47, 238-245.
32. 99mradiolabeled human antimicrobialpeptides for infection specific imaging. Mini Rev. Med.Chem. 2008, 8, 1039-1052.
33. Gemmel, F.; Dumarey, N.; Welling, W. FurtureDiganostic Agents.Semin. Nucl. Med. 2009, 39, 2-10.
34. Nham, T.; Filali, S.; Danne, C.; Derbise, A.; Carniel, E. Imaging ofbubonic plague dynamics by in vivo tracking of bioluminescentYerseniapestis. PLos One.2012, 7, e34717.
35. Pribaz, J.R.; Bernthal, N.M.; Bill, F.; Cho, J.S.; Ramos, R.I.; Guo, Y.; Cheung, A.L.; Francis, K.P.; Miller, L.S. Mouse model ofchronic post-arthroplasty infection: noninvasive in vivo bioluminescenceimaging to monitor bacterial burden for long-term study.J. Orthop. Res. 2012, 30, 335-340.
36. Zelmer, A.; Carroll, P.; Andreu, N.; Hagens, K.; Mahlo, J.; Redinger, N.; Roberston, B.D.; Wiles, S.; Ward, T.H.; Parish, T.; Ripoll, J.; Bancroft, G.J.; Schaible, U.E. A new in vivo model totest anti-tuberculosis drugs using fluorescence imaging. J. Antimicrob.Chemother. 2012, 67, 1948-1960.
37. Warawa, J.M.; Long, D.; Rosenke, R.; Gardner, D.; Gherardini, F.C. Bioluminescent diagnostic imaging to characterize altered respiratorytract colonization by the Burkholderiapseudomallei capsulemutant. Front. Microbiol. 2011, 2:133. doi:10.3389/fmicb.2011.00133.
38. Bashkatov, A. N.; Genina, E. A.; Kochubey, V. I.; Tuchin, V. V. Optical properties of human skin, subcutaneous and mucous tissuesin the wavelength range from 400 to 2000 nm. J. Phys. D.: Appl.Phys. 2005, 2543-2555.
39. James, M.L.; Gambhir S.S. A molecular imaging primer: modalities,imaging agents, and applications. Physiol. Rev. 2012, 92, 897-965.
40. Ngo, H.T.; Liu, X.; Jolliffe, K.A. Anion recognition and sensingwith Zn(II)-dipicolylamine complexes. Chem. Soc. Rev. 2012, 41,4928-4965.
41. 99mTc glucarate. Mol. Imaging. 2012, 11, 187-196.
42. Hanshaw, R.G.; Lakshmi, C.; Lambert, T.N.; Johnson, J.R.; Smith, B.D. Fluorescent detection of apoptotic cells by using zinc coordinationcomplexes with selective affinity for membrane surfaces enrichedwith phosphatidylserine. Chembiochem. 2005, 6, 2214-2220.
43. Smith, B. A.; Akers, W. J.; Leevy, W. M.; Lampkins, A. J.; Xiao, S.; Wolter, W.; Suckow, M. A.; Achilefu, S.; Smith, B. D. Opticalimaging of mammary and prostate tumors in living animals using asynthetic near infrared zinc(ii)-dipicolylamine probe for anioniccell surfaces. J. Am. Chem. Soc. 2010, 132(1), 67-69.
44. Smith, B. A.; Gammon, S. T.; Xiao, S.; Wang, W.; Chapman, S.; McDermott R.; Suckow, M. A.; Johnson, J.R.; Piwnica-Worms, D.;Gokel, G. W.; Smith, B. D.; Leevy, W. M. In vivo optical imagingof acute cell death using a near-infrared fluorescent zincdipicolylamineprobe.Mol. Pharm. 2011, 8(2), 583-590.
45. Ning, X.; Lee, S.; Wang, Z.; Kim, D.; Stubblefield, B.; Gilbert, E.; Murthy, N. Maltodextrin-based imaging probes detect bacteria invivo and with high sensitivity and specificity. Nat. Mater. 2011, 10,602-607.
46. Nam, S.; Chen, X.; Lim, J.; Kim, S. H.; Kim, S. T.; Cho, Y.; Yoon, J.; Park, S. In vivo Fluorescence Imaging of Bacteriogenic Cyanidein the Lungs of Live Mice Infected with Cystic Fibrosis Pathogens.PLoS ONE. 2011, 6, e21387.
47. 68Ga-Siderophores forPET imaging of invasive pulmonary aspergillosis: proof of principle. J. Nucl. Med. 2010, 51, 639-645.
48. Kong, Y.; Yao, H.; Ren, H.; Subbian, S.; Cirillo, S.L.; Sacchettini, J.C.; Rao, J.: Cirrillo, J.D. Imaging tuberculosis with endogenous-lactamase reporter enzyme fluorescence in mice. Proc. Natl.Acad. Sci. 2010, 107, 12239-12244.